Drug Shortage Report for SUTENT
Report ID | 159958 |
Drug Identification Number | 02280817 |
Brand name | SUTENT |
Common or Proper name | SUTENT |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SUNITINIB |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 28's |
ATC code | L01EX |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-05-04 |
Estimated end date | 2022-07-08 |
Actual end date | 2022-06-07 |
Shortage status | Resolved |
Updated date | 2022-06-08 |
Company comments | On preventive allocation. 12.5mg & 25mg Strengths available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-06-08 | French | Compare |
v5 | 2022-06-08 | English | Compare |
v4 | 2022-06-08 | English | Compare |
v3 | 2022-05-05 | English | Compare |
v2 | 2022-05-04 | French | Compare |
v1 | 2022-05-04 | English | Compare |
Showing 1 to 6 of 6